Cargando…
Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours
BACKGROUND: Metastatic brain tumours are a common end stage of breast cancer progression, with significant associated morbidity and high mortality. Walker 256 is a rat breast carcinoma cell line syngeneic to Wistar rats and commonly used to induce secondary brain tumours. Previously there has been t...
Autores principales: | Lewis, Kate M, Harford-Wright, Elizabeth, Vink, Robert, Ghabriel, Mounir N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576291/ https://www.ncbi.nlm.nih.gov/pubmed/23374226 http://dx.doi.org/10.1186/1475-2867-13-5 |
Ejemplares similares
-
The Fate of Circulating Walker 256 Tumour Cells injected Intravenously in Rats
por: Griffiths, J. D., et al.
Publicado: (1963) -
Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors
por: Harford-Wright, Elizabeth, et al.
Publicado: (2014) -
Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells
por: Jeney, A., et al.
Publicado: (2016) -
A comparison of the effects of cytotoxic agents on the Walker 256 tumour growing in the rat and at the hamster cheek pouch.
por: Smith, G. M.
Publicado: (1969) -
Leucine-rich diet supplementation modulates foetal muscle protein metabolism impaired by Walker-256 tumour
por: Cruz, Bread, et al.
Publicado: (2014)